
Vaxcyte Surges, Harley Davidson Gains, CH Robinson Drops on News it Will Buy RXO for $5.8 Billion
On this episode of Stock Movers:
- Vaxcyte (PCVX) shares surge. The pharmaceutical firm said that VAX-31, its experimental vaccine to prevent invasive pneumococcal disease (IPD) and pneumococcal pneumonia, met all primary endpoints in the OPUS-1 pivotal Phase 3 adult trial, compared to PCV20 and PCV21.
- Harley Davidson (HOG) shares gain. Citi upgraded the motorcycle company to buy from neutral, writing that an acceleration in retail growth is “tough to ignore.” What began as modest retail improvement early in 2026 now appears to be building, with 2027 likely to benefit from a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.